医学
原发性中枢神经系统淋巴瘤
中枢神经系统
甲氨蝶呤
淋巴瘤
放射治疗
脑脊液
神经毒性
肿瘤科
化疗
挽救疗法
临床试验
内科学
毒性
作者
Ugonma Nnenna Chukwueke,Christian Grommes,Lakshmi Nayak
标识
DOI:10.1016/j.hoc.2021.09.004
摘要
Primary central nervous system lymphoma is a rare and aggressive extranodal non-Hodgkin lymphoma restricted to the brain, spinal cord, cerebrospinal fluid , and eyes. Optimization of treatment including high-dose methotrexate-based chemotherapy followed by consolidation therapy in the form of autologous stem cell transplant or whole-brain radiation leads to improved survival. However, several patients do not respond to upfront therapy and the relapse risk is high. Additionally, there is a risk of delayed neurotoxicity , particularly in older patients. Recent molecular insights underlying the pathophysiology of PCNSL have led to the development of clinical trials involving targeted therapies and immunotherapies for salvage.
科研通智能强力驱动
Strongly Powered by AbleSci AI